−£1.23m
vs Dec 2024Active08028515Private limited companyCambridge
CYPRALIS LIMITED
Significant control: Hans Georg Fliri (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cypralis Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CYPRALIS LIMITED is an active private limited company (company number 08028515) incorporated on 12 April 2012, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£1.23m and cash of £2,143, with 2 employees on average. Net assets fell 10% on the prior period (−£1.13m). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Dr Hans Georg Fliri
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 April 201214 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 26 April 2027in 185 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£2,143
+57%vs Dec 2024Not reported
2
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£1.23m | £2,143 | — | £1.24m | — | — | 2 |
| 31 December 2024 | −£1.13m | £1,361 | — | £1.14m | — | — | 2 |
| 31 December 2023 | −£1.13m | £402 | — | £1.13m | — | — | 3 |
Current ratio0.01Current assets ÷ creditors within one year
Cash per employee£1,072Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,232,088 at 31 December 2025
- Current assets below creditors within one yearCurrent ratio 0.01
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 12 April 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 185 days
- Accounts period endNet liabilities £1.23m · small accounts
- Accounts period endNet liabilities £1.13m · small accounts
- Accounts period endNet liabilities £1.13m · small accounts
- Incorporated
08
Similar companies in Cambridge
- TRANSTHERA LTDCambridge · inc. Apr 2012
- BIOMODAL LIMITEDSaffron Walden · inc. Mar 2012
- CAMBRIDGE ONCOMETRIX LIMITEDHaverhill · inc. Jun 2012
- NERRE THERAPEUTICS LTDCambridge · inc. Jan 2012
- CHEMICAL INTELLIGENCE LIMITEDCambridge · inc. Aug 2012
- REVOLO BIOTHERAPEUTICS LIMITEDCambridge · inc. Oct 2011
All companies incorporated on 12 April 2012 · in Apr 2012.
09
Reminders for CYPRALIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.